Stay updated on RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe Record History shows a new revision entry (v3.3.4) and removal of the previous revision (v3.3.3). These changes reflect internal site version updates and do not alter trial data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedAdded Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check45 days agoChange DetectedThe history now shows a new revision entry, v3.3.2, replacing v3.3.1.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision entry (v3.3.1) was added and an earlier revision (v3.2.0) was removed. This update affects version-tracking information in the page history and does not alter study data or page functionality.SummaryDifference0.1%

- Check60 days agoChange DetectedDeleted the notice about a lapse in government funding that warned information may not be up to date and directed users to opm.gov for operating status updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check74 days agoChange DetectedNew versions appear in the record history up to 2025-05-13, and an IPDSharing field is now noted in the study record; the core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page.